2014
DOI: 10.1186/s13054-014-0461-9
|View full text |Cite
|
Sign up to set email alerts
|

There’s life in the old dog yet: vitamin C as a therapeutic option in endothelial dysfunction

Abstract: The use of vitamin C against different diseases has been controversially and emotionally discussed since Linus Pauling published his cancer studies. In vitro and animal studies showed promising results and explained the impact of vitamin C, particularly in cases with endothelial dysfunction. Indeed, studies (reviewed in this issue of Critical Care by Oudemans-van Straaten and colleagues) using high-dose vitamin C and the parenteral route of application seem to be more successful than oral vitamin C delivery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 12 publications
0
8
0
Order By: Relevance
“…18,19 Ascorbic acid prevents reactive oxygen species generation through the NADPH oxidase, inducible NO synthase, and by reductive recycling of tetrahydrobiopterin. 20 These effects occur when high doses of ascorbic acid are administered intravenously as in the sepsis trial recently reported by Fowler et al 21 Furthermore, high dose intravenous AA significantly reduces both vasopressor requirements as well as 28-day mortality in surgical critically ill patients. 22 In patients with sepsis treated with intravenous AA significant reductions in C reactive protein and thrombomodulin occurred which suggests reduced inflammation and reduced vascular injury.…”
Section: Discussionmentioning
confidence: 98%
“…18,19 Ascorbic acid prevents reactive oxygen species generation through the NADPH oxidase, inducible NO synthase, and by reductive recycling of tetrahydrobiopterin. 20 These effects occur when high doses of ascorbic acid are administered intravenously as in the sepsis trial recently reported by Fowler et al 21 Furthermore, high dose intravenous AA significantly reduces both vasopressor requirements as well as 28-day mortality in surgical critically ill patients. 22 In patients with sepsis treated with intravenous AA significant reductions in C reactive protein and thrombomodulin occurred which suggests reduced inflammation and reduced vascular injury.…”
Section: Discussionmentioning
confidence: 98%
“…Moreover, healthy platelets incubated with septic serum results in post-trascriptional changes including tissue factor pre-mRNA splicing that could be involved in increasing pro-coagulant activity in sepsis [ 57 ]. Interesting new evidence of the possible benefit of antioxidants and radical oxygen species scavengers (e.g., high doses of intravenous vitamin C in septic shock [ 58 ]) have recently been published and appear promising [ 59 , 60 ]. However, further studies on reversal of mitochondrial dysfunction in sepsis are needed.…”
Section: Mechanisms Of Platelet-mediated Organ Damage In Sepsismentioning
confidence: 99%
“…Irrespective of these giants contribution, interest in ascorbic acid use in diseases and cancer in particular went down. Recently one can see the revival of ascorbic acid and has shown many promising directions ranging from cancer to septic shock (13,208) and to reach high plasma levels of ascorbic acid it has to be used intravenously (209).…”
Section: Pauling Gyorgyi Warburg and Ascorbic Acidmentioning
confidence: 99%